← OSL

OSLONCOSIL MEDICAL LTD

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
20 Aug 2026, 19:22Change in substantial shareholding from AEFSubstantial Holders—02002
18 Aug 2026, 02:46Application for quotation of securities - OSLOther—06020
18 Aug 2026, 01:09Investor Webinar PresentationPresentations—03026
17 Aug 2026, 18:35OncoSil Receives FDA Approval for Distal CholangiocarcinomaCompany UpdateMS11001, 14014
30 July 2026, 18:42Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19004, 19009
24 July 2026, 18:40New Independent Study Confirms OncoSil Dose FlexibilityCompany Update—11001
24 July 2026, 01:25Application for quotation of securities - OSLOther—06020
20 July 2026, 18:31OncoSil Medical Receives Saudi Arabia FDA ApprovalCompany Update—11001
18 July 2026, 01:31Application for quotation of securities - OSLOther—06020
15 July 2026, 18:57Investor PresentationPresentations—03026
14 July 2026, 18:54OSPREY Registry Abstract Accepted for EANM 2026 CongressCompany Update—11001
13 July 2026, 18:39OncoSil Medical Completes Manufacturing ValidationCompany UpdateMS11001
6 July 2026, 18:49TRIPP-FFX Results Presented at ESMO GI 2026Company Update—11001
3 July 2026, 18:27OncoSil Medical Files for FDA ApprovalCompany UpdateMS11001
2 July 2026, 18:46OncoSil Selected for Major European Pancreatic Cancer StudyCompany UpdateMS11001
30 June 2026, 18:47TRIPP-FFX Abstract Published on ESMO GI 2026 WebsiteCompany Administration—12008
30 June 2026, 01:54Notice under ASX Listing Rule 3.10ASecurities Administration—06009
12 June 2026, 19:04Publication verifies OncoSil strong localisation in pancreasCompany Update—11001
12 June 2026, 18:30OncoSil Medical Launches Investor HubPresentations—14014
11 June 2026, 20:12Change in substantial shareholding from AEFSubstantial Holders—02002
10 June 2026, 19:04TRIPP FFX accepted for oral presentation at ESMO GI 2026Company Update—11001
9 June 2026, 19:48US FDA HDE and TRIPP-FFX Study PresentationPresentations—03026
9 June 2026, 19:48OncoSil progresses HDE with US FDACompany UpdateMS11001, 14014
9 June 2026, 19:47TRIPP-FFX Clinical Trial Meets Co-Primary EndpointsCompany UpdateMS09014, 11001, 14014
4 June 2026, 19:09Trading HaltTrading Halt / SuspensionMS09007
1 June 2026, 18:59TRIPP FFX Clinical Trial to Report Results in JuneCompany Update—11001
28 May 2026, 19:05Key New Ethics Approval for Italian Patient RegistryCompany Update—11001
28 May 2026, 01:22Application for quotation of securities - OSLOther—06020
28 May 2026, 01:20Notification regarding unquoted securities - OSLOther—06021
26 May 2026, 01:49Appointment of Company SecretaryCompany Administration—12007
22 May 2026, 19:14New Clinical Evidence for OncoSil Device Presented at ASCOCompany Update—11001, 12008
20 May 2026, 19:17OncoSil Medical Receives TGA Approval in AustraliaCompany UpdateMS11001
15 May 2026, 18:31OSPREY Interim Results Presented at ESGE Days 2026Company Update—11001
28 Apr 2026, 19:33Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19003, 19008
10 Apr 2026, 19:46Change of Share Registry DetailsSecurities Administration—12004
8 Apr 2026, 19:29OSPREY Registry Data Accepted for Presentation at ESGE DaysCompany Update—11001
21 Mar 2026, 06:21Change in substantial holding from SOLSubstantial Holders—02002
20 Mar 2026, 03:57Becoming a substantial holderSubstantial Holders—02001
20 Mar 2026, 00:40Change in substantial holding from PCGSubstantial Holders—02002
19 Mar 2026, 22:08Change of Director's Interest Notice X2Director Interests—02009
19 Mar 2026, 22:07Late Lodgement of Appendix 3YDirector Interests—02009
18 Mar 2026, 19:49Security Class Reinstatement to Quotation - OSLOEReinstatementMS09002
17 Mar 2026, 23:03Notice Under Section 708ASecurities Administration—06018
17 Mar 2026, 23:01Top 20 Holders and Range of Units for Attaching OptionsSecurities Administration—03002, 06009
17 Mar 2026, 22:55Application for quotation of securities - OSLOther—06020
17 Mar 2026, 22:44Application for quotation of securities - OSLOther—06020
17 Mar 2026, 22:40Application for quotation of securities - OSLOther—06020
17 Mar 2026, 22:40Application for quotation of securities - OSLOther—06020
17 Mar 2026, 19:51Results of Entitlement OfferCapital Raising—06008
12 Mar 2026, 22:46Results of MeetingMeetings & Governance—08003
1–50 of 116
1 / 3